Surrogacy in North Cyprus: Medical Eligibility, Legal Requirements and IVF Process
Surrogacy may be considered in selected situations where a woman cannot safely carry a pregnancy in her own uterus or where pregnancy may create a serious health risk. In the Turkish Republic of Northern Cyprus (TRNC), use of a gestational carrier is not an unrestricted treatment option: medical indication, carrier eligibility and the required official approval pathway must be considered together.
Defines medical circumstances in which use of a gestational carrier may be considered.
A regulatory age criterion; it does not by itself establish eligibility.
Embryos are created in the laboratory and transferred after endometrial preparation.
Treatment cannot be finalised before required documentation and official procedures are completed.
What Is Surrogacy? How Does Gestational Surrogacy Work?
Surrogacy is an assisted reproduction pathway in which an embryo is transferred to a woman who carries the pregnancy. The modern IVF model is usually described as gestational surrogacy or use of a gestational carrier.
The carrier provides the pregnancy environment. The embryo’s genetic contribution comes from the egg and sperm used to create it. Which gametes may be used must be assessed according to the intended parent’s medical situation and the legal treatment pathway that applies.
An embryo is created
Eggs and sperm are used to create embryos by IVF or ICSI according to the clinical plan.
The uterus is prepared
The gestational carrier’s endometrium is prepared and synchronised with the embryo-transfer plan.
Embryo transfer
A suitable embryo is transferred according to clinical, laboratory and legal requirements.
Is Surrogacy Legal in North Cyprus? What Does the TRNC Regulation Require?
Use of a gestational carrier is specifically addressed in the TRNC regulation governing assisted reproduction centres and methods. The regulation identifies medical situations in which a gestational carrier may be considered and sets basic requirements for the carrier.
Surrogacy is not an unrestricted “on request” treatment
An eligible medical indication must be documented. The pathway involves the competent authority, application to the Coordination Board (Koordinasyon Kurulu), identity and medical information, and the required information-and-consent procedures.
Why a gestational carrier is medically necessary
The condition making pregnancy impossible or seriously unsafe must be supported by the relevant clinical records.
Board assessment and consent
Required documentation, information and consent procedures are completed before treatment is finalised.
This page summarises the Turkish-language regulation for international patients. It is not an official English translation. The official Turkish text and current competent-authority practice should be checked again before treatment.
Who May Be Considered for Surrogacy in North Cyprus?
Article 27 lists medical circumstances in which use of a gestational carrier may be considered. Meeting one of these descriptions does not automatically mean approval will be granted: each case is assessed individually.
Congenital absence of the uterus
Women born without a uterus may be assessed for a gestational carrier pathway when the necessary medical documentation is available.
Previous hysterectomy
Surgical removal of the uterus following benign or malignant conditions is included among the circumstances described in the regulation.
Congenital uterine abnormalities
The regulation gives examples such as a T-shaped or hypoplastic uterus in the context of conditions that may prevent safe pregnancy.
Non-correctable uterine dysfunction
Cases in which uterine function cannot be corrected and pregnancy cannot be safely carried may require specialist assessment.
Pregnancy poses a serious threat to life
The regulation gives examples including serious heart disease and serious renal failure.
Selected serious medical or obstetric histories
Examples in the regulation include a history of breast cancer and severe HELLP syndrome, subject to individual medical review.
Repeated failed IVF cycles are not listed by themselves as a specific Article 27 indication. The underlying causes—embryo development, uterus, transfer, genetics and male factors—should first be investigated before surrogacy is discussed as an appropriate pathway.
Gestational Carrier Requirements: Age, Medical Assessment and Consent
Searches such as “surrogate mother requirements” often focus only on age. In practice, eligibility is broader: the candidate must be medically suitable for pregnancy and must participate voluntarily and with informed consent.
- Age 21–40: the age range specified in the TRNC regulation.
- Identity information: required for the official application file.
- Medical information: reviewed to assess pregnancy safety and suitability.
- Additional documents: further information may be requested by the Coordination Board.
- Informed consent: medical procedures, risks and responsibilities should be clearly explained.
- Voluntary participation: decisions should be free from pressure or coercion.
International good-practice perspective
ASRM guidance on gestational carriers supports comprehensive medical screening, preconception counselling, uterine-cavity assessment, infectious-disease testing, psychosocial evaluation and legal counselling. These are clinical good-practice principles and do not replace TRNC law.
How Is a Gestational Carrier Found and Evaluated?
“How do I find a surrogate?” is a common search, but a safe pathway is more than locating a willing individual. Medical suitability, voluntary participation, expectations, official approvals and cross-border legal planning all matter.
Identity and age
Basic regulatory criteria and identity information are verified.
Medical suitability
Health, pregnancy history and uterine suitability are assessed according to the clinical plan.
Consent and expectations
Pregnancy care, prenatal testing, communication and delivery-related decisions should be discussed in advance.
Independent legal review
Parentage, birth registration, citizenship and cross-border recognition may require specialist legal advice.
For international intended parents in particular, the legal effect of a birth in the TRNC should be reviewed in the country or countries connected to the intended parents and the child.
Is the Gestational Carrier the Biological Mother? Who Is the Baby Genetically Related To?
Gestational role, genetic contribution and legal parenthood are separate concepts.
One part of the genetic contribution
The egg contributes part of the embryo’s nuclear genetic material.
The other part of the genetic contribution
The sperm contributes the other part of the embryo’s nuclear genetic material.
Provides the pregnancy environment
The carrier carries the embryo in her uterus; genetic contribution depends on the gametes used.
How can the embryo be created?
The intended parent’s own eggs and sperm may be usable in some cases. In others, a donation pathway may need to be assessed separately. The correct approach depends on ovarian reserve, sperm factors, genetic considerations and the applicable legal framework.
- Can the intended mother’s own eggs be used?
- What does the semen analysis show?
- Is egg or sperm donation medically relevant?
- Should embryo donation be considered as a separate treatment option?
- Is targeted PGT-M or PGT-SR indicated because of a known genetic risk?
How Does the Surrogacy Process Work in North Cyprus?
The exact sequence depends on the patient’s medical file, the gestational carrier and the official pathway, but the following steps show how a typical gestational-surrogacy plan may be organised.
Medical-file review
Diagnosis, surgical history, uterine status, pregnancy risks and previous IVF records are reviewed.
Documenting the medical indication
The reason a gestational carrier is medically required is supported by specialist assessment and relevant tests.
Carrier assessment
Age, identity, medical information, pregnancy safety and any additional required tests are reviewed.
Official application and approval
The required documentation is prepared for the competent authority and Coordination Board process.
Information and consent
Required information and consent documents are completed with the intended parent(s) and carrier.
Egg and sperm planning
Ovarian reserve, semen analysis, previous treatment and any genetic indication are considered.
IVF / ICSI and embryo culture
Eggs are fertilised and embryos are cultured under controlled laboratory conditions.
Genetic testing if indicated
PGT is not routine for every patient; it may be used when a specific genetic indication exists.
Endometrial preparation
The carrier’s endometrium is prepared and progesterone timing is matched to the embryo stage.
Embryo transfer and pregnancy testing
A suitable embryo is transferred, followed by beta-hCG testing and clinical pregnancy follow-up.
How Long Does the Surrogacy Process Take?
There is no reliable one-size-fits-all answer. Medical documentation, official approval, IVF preparation, embryo development, genetic testing where required and the carrier’s endometrial preparation all affect timing.
| Stage | What happens? | What may affect timing? |
|---|---|---|
| Initial review | Medical records, surgical history, diagnosis and prior IVF records are assessed. | Missing tests or specialist reports |
| Official process | Required application, approval and consent documents are prepared. | File complexity and additional requests |
| IVF / embryo phase | Gamete planning, fertilisation, embryo culture and freezing where relevant. | Egg source, stimulation and embryo development |
| Transfer preparation | The gestational carrier’s endometrium and hormone timing are assessed. | Natural versus programmed cycle |
| Pregnancy follow-up | Beta-hCG, ultrasound and obstetric follow-up are arranged. | Clinical course of the pregnancy |
The first medical-file review and part of the travel planning may begin remotely. The dates on which you need to be in Cyprus should be finalised only after the individual treatment and official schedule is clear.
Surrogacy Cost in Cyprus: What Determines the Total Treatment Cost?
Search terms such as “surrogacy cost Cyprus” or “surrogate mother price” can suggest that there should be one standard figure. In reality, the total scope depends on which medical, laboratory and official steps are necessary in the individual case.
Medical assessment
Specialist consultations, imaging and any additional tests required for eligibility.
IVF / ICSI
Medication, egg collection when required, fertilisation and embryo culture.
Gamete source
Use of own gametes or separately assessed donation pathways where medically and legally appropriate.
Embryo freezing and storage
Vitrification, storage duration and future warming procedures.
Genetic testing
PGT-M, PGT-SR or other testing only where clinically indicated.
Transfer and follow-up
Endometrial preparation, embryo transfer and early pregnancy follow-up.
Start with the medical file, not a package price
A personalised written scope makes it clear which procedures are actually necessary and avoids mixing optional and essential treatment components.
Share your current reports so the necessary treatment stages can be clarified.
Review my medical fileSurrogacy Success Rates: What Actually Determines the Chance of Pregnancy?
There is no single “surrogacy success rate” that applies to every patient. The age and source of the egg, embryo development, sperm factors, laboratory quality, the carrier’s uterine health and the embryo-transfer plan all influence outcome.
Age and egg source
A major determinant of embryo chromosomal competence and developmental potential.
Embryo development
Fertilisation, blastocyst development and laboratory assessment influence transfer options.
Carrier uterine health
Endometrium, uterine cavity and overall pregnancy health are assessed together.
Laboratory and transfer
Culture conditions, identity control, freezing/warming and transfer technique all matter.
No. Even when there is a medically suitable carrier and a well-developing embryo, implantation failure, miscarriage and pregnancy complications remain possible.
Surrogacy Risks and Limitations
Good decision-making requires understanding not only whether treatment is possible, but also the medical, psychological and cross-border legal uncertainties involved.
Pregnancy and delivery risks
A gestational carrier can experience hypertensive disorders, gestational diabetes, preterm birth, caesarean delivery and other obstetric complications.
IVF and embryo uncertainty
Fertilisation may fail, embryos may not reach blastocyst, transfer may not implant or miscarriage may occur.
Multiple-pregnancy risk
Transfer of more than one embryo may increase maternal and neonatal risks and should be assessed carefully.
Psychosocial considerations
Communication, expectations, pregnancy decisions and the relationship after birth may require structured counselling.
Cross-border legal uncertainty
Legal parentage, citizenship and birth registration may not be recognised in the same way in every country.
Limits of genetic testing
PGT, when used, does not exclude every genetic condition or congenital anomaly and does not replace appropriate prenatal care.
Cross-Border Surrogacy in North Cyprus: What Should International Patients Plan?
A treatment pathway that can be medically and officially carried out in the TRNC does not automatically determine legal parentage, citizenship, passport eligibility or birth registration in another country.
- Parentage-recognition rules in your country of citizenship or residence
- Birth-certificate and civil-registration procedures
- Citizenship and passport requirements for the child
- Any required court or administrative recognition procedure
- Independent legal advice for intended parents and the gestational carrier where appropriate
- Travel, delivery and post-birth stay planning
Cross-border parentage and citizenship outcomes vary according to nationality, residence, place of birth and current law. Individual legal advice should be obtained before treatment.
Which Medical Documents Are Useful for an Initial Surrogacy Assessment?
Sharing relevant records early can make the first medical review more focused and efficient.
- Operative notes or reports documenting congenital absence of the uterus or hysterectomy
- Relevant pathology or oncology records where applicable
- Cardiology, nephrology or other specialist reports for serious medical conditions
- Previous pregnancy and delivery records
- Previous IVF / ICSI treatment summaries
- AMH and ovarian-reserve assessments
- Semen analysis and male-factor infertility records
- Known genetic or carrier-screening reports
- Current medication and significant chronic-health information
- Identity/passport information and any further documents requested during the official process
Surrogacy in North Cyprus: Frequently Asked Questions
Answers to common questions about surrogacy law, gestational carrier requirements, genetic relationship, IVF, cost, success rates, treatment duration and international patients.
What is surrogacy?
Surrogacy is an assisted reproduction pathway in which an embryo is transferred to another woman who carries the pregnancy. In gestational surrogacy, the gestational carrier is not the source of the egg unless a separate and legally permissible treatment pathway applies.
Is surrogacy legal in North Cyprus?
Use of a gestational carrier is specifically regulated in the TRNC assisted reproduction regulation. It is not an unrestricted treatment for every applicant. Medical eligibility must be documented and the required competent-authority and Coordination Board procedures must be completed.
Who may be considered for surrogacy in North Cyprus?
The regulation lists medical situations including congenital absence of the uterus, surgical removal of the uterus, certain congenital or non-correctable uterine conditions, and serious medical circumstances in which pregnancy may endanger the woman’s life. Each case still requires individual medical and official assessment.
What age must a gestational carrier be?
The TRNC regulation states that a gestational carrier candidate should be between 21 and 40 years of age. Age alone does not establish eligibility; identity, medical information, pregnancy suitability, consent and any additional information requested by the authorities must also be considered.
What is the difference between a surrogate mother and a gestational carrier?
“Surrogate mother” is a common search term, while “gestational carrier” is the more precise clinical term for a woman who carries an embryo created from other gametes. The genetic relationship depends on the egg and sperm used to create the embryo.
How is a gestational carrier selected?
Selection is not simply a matching exercise. The candidate’s age, medical and obstetric suitability, informed and voluntary participation, identity documentation, psychosocial considerations, legal planning and the official approval pathway all need to be addressed.
How do intended parents find a gestational carrier?
Potential arrangements must be evaluated within the applicable legal and medical framework. A clinic can assess medical suitability, but independent legal advice is important for parentage, agreements, birth registration, citizenship and cross-border consequences.
Is the gestational carrier the genetic mother of the baby?
In gestational surrogacy, the carrier provides the pregnancy environment. The embryo’s genetic contribution comes from the egg and sperm used to create it. The clinical and legal significance of parentage should be discussed separately because genetic, gestational and legal parenthood are different concepts.
Whose eggs are used in surrogacy?
The egg source depends on the intended parent’s medical situation and the legally applicable treatment plan. In some cases the intended mother’s own eggs may be used; in others, a donation pathway may need to be evaluated separately.
Whose sperm is used in surrogacy?
The sperm source is determined according to the individual treatment plan. Semen analysis, male-factor infertility, genetic considerations and the applicable legal framework are reviewed before IVF or ICSI is planned.
Does surrogacy require IVF?
Gestational surrogacy requires embryos to be created in an IVF laboratory. Eggs are fertilised using IVF or ICSI, embryos are cultured, and a suitable embryo is transferred after the gestational carrier’s endometrium has been prepared.
Can PGT be used in a surrogacy cycle?
PGT is not mandatory in every surrogacy cycle. It may be considered when there is a specific genetic or chromosomal indication. The appropriate test—such as PGT-M or PGT-SR—should be selected through genetic counselling and clinical review.
What is the success rate of surrogacy?
There is no single success rate that applies to everyone. Outcomes depend on egg age and source, sperm factors, embryo development, laboratory conditions, uterine and general health of the gestational carrier, transfer strategy and other clinical variables. No method can guarantee pregnancy or live birth.
How much does surrogacy cost in Cyprus?
A single standard price can be misleading. The total treatment scope may include medical assessments, official procedures, IVF/ICSI, medication, gamete source, embryo culture, freezing, genetic testing when indicated, transfer and follow-up. A written personalised treatment scope should be prepared after the medical file is reviewed.
How long does the surrogacy process take?
There is no fixed timeline. Medical documentation and official approval, IVF preparation, ovarian stimulation where required, embryo development, any genetic testing, endometrial preparation and the timing of embryo transfer all affect the overall schedule.
Can a woman born without a uterus apply for surrogacy?
Congenital absence of the uterus is one of the medical circumstances specifically listed in the TRNC regulation as a situation in which use of a gestational carrier may be considered, subject to documentation and official approval.
Can a woman who has had a hysterectomy apply for surrogacy?
The regulation includes removal of the uterus following benign or malignant conditions among the situations in which use of a gestational carrier may be considered. Individual health status and the required official procedures still apply.
Is recurrent IVF failure alone an indication for surrogacy?
Recurrent IVF failure is not listed on its own as a specific indication in Article 27. The underlying reason for failed treatment should first be investigated, including embryo, uterine, genetic, male-factor and transfer-related causes.
What medical tests are performed on a gestational carrier?
The TRNC regulation requires medical information and allows the authorities to request additional information. International clinical guidance also supports preconception medical review, uterine assessment, infectious-disease screening and psychosocial counselling. The exact tests should follow local requirements and physician judgement.
What should international patients consider before surrogacy in North Cyprus?
Treatment being medically and officially permissible in the TRNC does not automatically resolve legal parentage, birth registration, citizenship or passport issues in another country. Independent legal advice in the relevant jurisdictions should be obtained before treatment begins.
How many embryos are transferred in surrogacy?
The number of embryos transferred should be decided according to prognosis, embryo quality, the risk of multiple pregnancy and the applicable legal and clinical standards. The objective is not simply to achieve pregnancy, but to support the safest possible pregnancy.
How is pregnancy followed after embryo transfer?
After pregnancy is confirmed, obstetric care is coordinated in the same way that a high-quality pregnancy pathway would be managed, with attention to prenatal screening, maternal health, medication, pregnancy complications and delivery planning.
Can the first surrogacy consultation be done online?
Yes. Existing medical reports, surgical history and previous IVF records can be reviewed remotely for an initial assessment. Final eligibility depends on examination, testing, documentation and completion of the required official procedures.
Let’s Clarify Your Medical Eligibility and the Surrogacy Pathway Before You Plan Treatment
Share your medical reports, surgical history and previous IVF records to begin an initial review. The medical, laboratory and official steps can then be explained according to your individual case.